MDXG
Price
$6.85
Change
-$0.00 (-0.00%)
Updated
Nov 1 closing price
120 days until earnings call
RCKT
Price
$16.65
Change
-$0.00 (-0.00%)
Updated
Nov 1 closing price
2 days until earnings call
Ad is loading...

MDXG vs RCKT

Header iconMDXG vs RCKT Comparison
Open Charts MDXG vs RCKTBanner chart's image
MiMedx Group
Price$6.85
Change-$0.00 (-0.00%)
Volume$2.47K
CapitalizationN/A
Rocket Pharmaceuticals
Price$16.65
Change-$0.00 (-0.00%)
Volume$2.52K
CapitalizationN/A
View a ticker or compare two or three
MDXG vs RCKT Comparison Chart
Loading...
MDXG
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
MDXG vs. RCKT commentary
Nov 04, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDXG is a Buy and RCKT is a Sell.

COMPARISON
Comparison
Nov 04, 2024
Stock price -- (MDXG: $6.85 vs. RCKT: $16.65)
Brand notoriety: MDXG and RCKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MDXG: 0% vs. RCKT: 0%
Market capitalization -- MDXG: $1.02B vs. RCKT: $1.54B
MDXG [@Biotechnology] is valued at $1.02B. RCKT’s [@Biotechnology] market capitalization is $1.54B. The market cap for tickers in the [@Biotechnology] industry ranges from $494.31B to $0. The average market capitalization across the [@Biotechnology] industry is $2.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MDXG’s FA Score shows that 1 FA rating(s) are green whileRCKT’s FA Score has 0 green FA rating(s).

  • MDXG’s FA Score: 1 green, 4 red.
  • RCKT’s FA Score: 0 green, 5 red.
According to our system of comparison, MDXG is a better buy in the long-term than RCKT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MDXG’s TA Score shows that 4 TA indicator(s) are bullish while RCKT’s TA Score has 2 bullish TA indicator(s).

  • MDXG’s TA Score: 4 bullish, 5 bearish.
  • RCKT’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, MDXG is a better buy in the short-term than RCKT.

Price Growth

MDXG (@Biotechnology) experienced а +17.09% price change this week, while RCKT (@Biotechnology) price change was -2.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

MDXG is expected to report earnings on Mar 04, 2025.

RCKT is expected to report earnings on Mar 06, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCKT($1.55B) has a higher market cap than MDXG($1.02B). MDXG YTD gains are higher at: -21.893 vs. RCKT (-44.444). MDXG has higher annual earnings (EBITDA): 66.8M vs. RCKT (-243.06M). RCKT has more cash in the bank: 279M vs. MDXG (69M). MDXG has less debt than RCKT: MDXG (19.2M) vs RCKT (25.8M). MDXG has higher revenues than RCKT: MDXG (340M) vs RCKT (0).
MDXGRCKTMDXG / RCKT
Capitalization1.02B1.55B66%
EBITDA66.8M-243.06M-27%
Gain YTD-21.893-44.44449%
P/E Ratio12.16N/A-
Revenue340M0-
Total Cash69M279M25%
Total Debt19.2M25.8M74%
FUNDAMENTALS RATINGS
MDXG vs RCKT: Fundamental Ratings
MDXG
RCKT
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
46
Fair valued
PROFIT vs RISK RATING
1..100
8287
SMR RATING
1..100
1297
PRICE GROWTH RATING
1..100
4680
P/E GROWTH RATING
1..100
92100
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RCKT's Valuation (46) in the Biotechnology industry is in the same range as MDXG (65). This means that RCKT’s stock grew similarly to MDXG’s over the last 12 months.

MDXG's Profit vs Risk Rating (82) in the Biotechnology industry is in the same range as RCKT (87). This means that MDXG’s stock grew similarly to RCKT’s over the last 12 months.

MDXG's SMR Rating (12) in the Biotechnology industry is significantly better than the same rating for RCKT (97). This means that MDXG’s stock grew significantly faster than RCKT’s over the last 12 months.

MDXG's Price Growth Rating (46) in the Biotechnology industry is somewhat better than the same rating for RCKT (80). This means that MDXG’s stock grew somewhat faster than RCKT’s over the last 12 months.

MDXG's P/E Growth Rating (92) in the Biotechnology industry is in the same range as RCKT (100). This means that MDXG’s stock grew similarly to RCKT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MDXGRCKT
RSI
ODDS (%)
Bearish Trend 3 days ago
76%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 17 days ago
84%
Declines
ODDS (%)
Bearish Trend 5 days ago
79%
Bearish Trend 4 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
80%
Aroon
ODDS (%)
Bearish Trend 3 days ago
81%
N/A
View a ticker or compare two or three
Ad is loading...
MDXG
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PCBSX14.310.09
+0.63%
BlackRock Tactical Opportunities Service
NWKEX33.790.11
+0.33%
Nationwide WCM Focused Sm Cp R6
VPCCX35.980.11
+0.31%
Vanguard PRIMECAP Core Inv
FSISX8.58N/A
N/A
Fidelity SAI International Sm Cp Idx
GWSCX13.37-0.05
-0.37%
Gabelli Focused Gr and Inc C

MDXG and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDXG has been loosely correlated with AVXL. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if MDXG jumps, then AVXL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDXG
1D Price
Change %
MDXG100%
N/A
AVXL - MDXG
51%
Loosely correlated
N/A
BEAM - MDXG
50%
Loosely correlated
N/A
RCKT - MDXG
49%
Loosely correlated
N/A
VCEL - MDXG
49%
Loosely correlated
-0.11%
RXRX - MDXG
49%
Loosely correlated
N/A
More

RCKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCKT has been loosely correlated with DNLI. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if RCKT jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCKT
1D Price
Change %
RCKT100%
N/A
DNLI - RCKT
56%
Loosely correlated
N/A
NTLA - RCKT
54%
Loosely correlated
+4.15%
RYTM - RCKT
53%
Loosely correlated
+2.68%
AXON - RCKT
52%
Loosely correlated
N/A
ALEC - RCKT
52%
Loosely correlated
+2.03%
More